Amneal Pharmaceuticals (AMRX) P/E (2018 - 2026)
Amneal Pharmaceuticals (AMRX) P/E from Oct 1, 2018 to Jul 21, 2026. The TTM Amneal Pharmaceuticals (AMRX) P/E is 57.42. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
P/E
Annual P/E change of Amneal Pharmaceuticals (AMRX)
| Year | P/E | Change |
|---|---|---|
| 2026 | 57.42 | -46.36% |
| 2025 | 107.04 | -392.75% |
| 2024 | -36.56 | -126.75% |
| 2023 | 136.68 | -12221.19% |
| 2022 | -1.13 | -102.09% |
| 2021 | 54.03 | -1896.46% |
| 2020 | -3.01 | +54.75% |
| 2019 | -1.94 | -100.78% |
| 2018 | 249.88 | N/A |
Comparison Amneal Pharmaceuticals (AMRX) P/E with competitors
Amneal Pharmaceuticals (AMRX) P/E is 57.42.